A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors
Clinical trial NCT05824663 · COMPLETED
Trial details
- NCT number
- NCT05824663
- Sponsor
- Harbour BioMed US, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2024-10-09
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.